


NAT-1/2 Antibody (A-1) is a mouse monoclonal IgM antibody that detects Arylamine N-acetyltransferase-1/2 (NAT-1/2) in mouse, rat, and human samples through applications such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). NAT-1/2 plays a crucial role in the detoxification of a diverse range of drugs by catalyzing the N- or O-acetylation of heterocyclic and arylamine substrates, which is vital for reducing the potential toxicity of these compounds. The activity of NAT-1/2 is particularly significant as certain alleles associated with high N-acetyltransferase activity have been linked to an increased risk of developing colon and urinary bladder cancers, highlighting the importance of understanding individual genetic variations in drug metabolism and cancer susceptibility. Both NAT-1 and NAT-2 are located in the cytoplasm, where NAT-1 and NAT-2 actively participate in the detoxification process, and NAT-1 and NAT-2 polymorphic nature in liver tissues can influence the efficacy and safety of drugs containing amines. Human NAT-1 serves as the functional homolog of rodent NAT-2, while human NAT-2 corresponds to rodent NAT-1, underscoring the evolutionary conservation of these enzymes across species. NAT-1/2 (A-1) antibody is an essential tool for researchers investigating the role of these enzymes in pharmacogenomics and cancer research.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
NAT-1/2 Antibody (A-1) | sc-393937 | 200 µg/ml | $322.00 | |||
NAT-1/2 (A-1) Neutralizing Peptide | sc-393937 P | 100 µg/0.5 ml | $69.00 |